ZTEK — Stock Film
STOCK FILMSCENE 1/11ZTEK · $0.49
Stock Expert AI presents
ZTEK
Zentek Ltd
~5 min film100% real numbersplain English
WHAT DOES THIS COMPANY DO?
Zentek Ltd. What it actually does.

Conducts research and development of graphene and related nanomaterials. Now — the numbers.

on the stock market since 2012
10 employees
$62.3M market value
Revenue last year:
$120K
The loss that same year:
$7.1M
For every $1 it earns, the company spends $60.

The company closed last year at a loss: costs ran above sales. The picture changes only if spending is reined in.

THE SALES TREND
Sales have been shrinking.

An average decline of 16% a year over the last 4 years — the most striking risk in this picture. Red columns mark years that ended in a loss.

$245K
2022
2023
2024
2025
$120K
2026
In the vault right now:
$942K
DEBT: $1.4M
At this pace, that money lasts less than a year.

Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.

THE PRICE TAG
MARKET VALUE / ANNUAL SALES
518.9×

This company is not turning a profit, so the market is pricing its sales instead: 518.9× for every dollar of annual revenue.

Against companies in its own sector, it looks cheaper than 9% of them.

No analyst target is on record for this company.

INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
2
very weak

Clearly below the class average.

FINANCIAL STRENGTH
64
average

A solid grade overall — yet the debt outweighs the cash. The strength here comes from earnings power.

VALUATION
9
very weak

Clearly below the class average.

GROWTH
37
weak

Clearly below the class average.

PRICE MOMENTUM
24
very weak

Clearly below the class average.

WORTH WATCHING

Business Quality: Profit power and business quality trail similar companies in the sector.

Valuation: The stock trades at a price that looks expensive next to its earnings; that can cap future returns.

THE FIVE-YEAR JOURNEY
A long and steep decline.

An investor who bought at the very peak is down 91% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.

1
THE BRIGHT SIDE · 1/1
Delivers on expectations

It met or beat analyst expectations in 8 of the last 8 quarters — consistency is a promise kept.

1
THE RISKS · 1/3
Small sales, big loss

A loss of $7.1M against $120K in annual sales. And on top of that, sales fell from the year before.

2
THE RISKS · 2/3
Trading under $1

The stock sits at $0.49. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.

3
THE RISKS · 3/3
The cash has a countdown

At the current pace of spending, the cash lasts less than a year. After that, the company needs to find new money.

FINALE · THE GRADE
F
25 / 100 · MoonshotScore

On our five-subject report card, ZTEK sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”

The takeaway: ZTEK’s sales are going backwards, and it closed last year at a loss. The road back runs through both.

What would you like to do next?
Open the stock page →

Not covered, because the filings we hold do not carry it: the revenue breakdown.

This was a film — not investment advice.
Data: FMP & company filings
Sep 12, 2026 · stockexpertai.com · Stock Film